Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›

Access in Bangladesh

South Asia ยท Tier 3

Regulatory framework

Bangladesh's DGDA accepts named-patient import under personal-use exceptions; volume is lower but pathway exists.

Typical timeline

For patients in Bangladesh requesting a specialty drug through Reserve Meds, the end-to-end timeline from initial request to drug delivery typically ranges 2-8 weeks. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

  1. Patient or physician submits a request with drug name and indication.
  2. We verify clinical appropriateness and document eligibility.
  3. Treating physician issues prescription and clinical justification.
  4. Country-specific regulatory documentation is prepared and submitted.
  5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
  6. Drug ships cold-chain to destination physician or hospital pharmacy.
  7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from Bangladesh

Lenmeldy

Metachromatic leukodystrophy

Kresladi

Leukocyte adhesion deficiency I

Elevidys

Duchenne muscular dystrophy

Lyfgenia

Sickle cell disease

Zevaskyn

Recessive DEB

Skysona

Cerebral adrenoleukodystrophy

Casgevy

Sickle cell disease; transfusion-dependent beta-thalassemia

Ryoncil

Pediatric SR-aGvHD

Tecelra

Synovial sarcoma

Encelto

Macular telangiectasia type 2

Qfitlia

Hemophilia A/B prophylaxis

Vyjuvek

Dystrophic epidermolysis bullosa

Review & oversight. Content on this page is reviewed by Reserve Meds's clinical and regulatory team. A US-licensed pharmacist reviews every prescription before dispensing. Regulatory posture is informational, not legal advice; case-specific questions route to retained outside counsel. Review methodology ›
Last medically reviewed: .